XD4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - STRABAG SE

Watchlist Manager

Watchlist

Price: 103 EUR 0.39%

Market Cap: €10.6B

S	STRABAG SE XMUN:XD4	AT
	Innate Pharma SA PAR:IPH	FR
	Lycopodium Ltd F:LW1	AU
U	Unique Mining Services PCL SET:UMS	TH
T	Tryg A/S F:T2V1	DK

Profitability Summary

STRABAG SE's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

41%

Sustainable 3Y Average Gross Margin

40%

Gross Margin is Increasing

36% > 41%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

3% > 5%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

3% > 5%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

6% > 7%

Positive ROE

18%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

41%

Sustainable 3Y Average Gross Margin

40%

Gross Margin is Increasing

36% > 41%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

3% > 5%

Low Net Margin

Low 3Y Average Net Margin